Streetwise Reports' Article Archives — Current Month (36)

Copper Company Closes 30% Share of Acquisition of Copper North Mining (12/09/2019)

The two companies are advancing adjoining projects in the Yukon.

more>

ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck (12/09/2019)

ArQule Inc. shares traded more than 100% higher today after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20.

more>

Young Company Plans to Bring Mexican Gold Deposit to Market in Two Years (12/09/2019)

Andrew Bowering, president of Prime Mining, talks with Maurice Jackson of Proven and Probable about his company's plans to fast track its gold project.

more>

Company Reports 'Robust PEA' for South Dakota Uranium Project (12/07/2019)

The report validates the Colorado-based company's strategy.

more>

Antibiotic Alternative for Livestock Feed Approved for Malaysia (12/07/2019)

Now, the company has the green light to sell this product in eight countries.

more>

Explorer More Than Doubles Drill Campaign at Red Lake District Project (12/07/2019)

The Canadian company announced a $21 million budget and aims to complete the expansion by year-end 2020.

more>

Explorer Gathers Data on Quebec Gold Property (12/06/2019)

Regional geology, mineral showings, historical drill results and magnetic survey results are among the information obtained.

more>

Explorer Options Majority Interest in Gold Project (12/06/2019)

Incubating and monetizing assets are among the company's strategic objectives.

more>

"High Potential' Targets Identified at Oaxaca Gold Project (12/06/2019)

The gold-silver company continues to advance the asset.

more>

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device (12/06/2019)

A new advancement in bladder-related endoscopic surgery is endorsed and de-risked.

more>

Cassava Sciences' Shares Trade Up 20% on Updated Phase 2a Alzheimer's Data (12/06/2019)

Shares of Cassava Sciences traded 20% higher after the firm presented additional data from the Phase 2a study of its investigational drug candidate PTI-125 for Alzheimer's disease to the Clinical Trials on Alzheimer's Disease conference in San Diego, Calif.

more>

'Huge Upside Potential' on Firm That Turns Plastic Waste into Synthetic Fuels (12/05/2019)

The rationale for investing in this company is provided in a Pareto Securities report.

more>

Junior Explorer Moves Forward in 'Prime Gold Real Estate' (12/05/2019)

Jay Taylor of J. Taylor's Gold, Energy & Tech Stocks examines the prospects of a company working in the exploration and development of Larder gold deposits along the Cadillac-Larder Lake Fault in Ontario.

more>

AR Tech Company Expands Deal with Manufacturer of James Bond PPK (12/05/2019)

The firm will now provide its Web-based, three-dimensional, augmented reality service to the client.

more>

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data (12/05/2019)

Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20.

more>

Immuno-Oncology Firm Expands Agreement with AbbVie (12/04/2019)

The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report.

more>

Bitumen Resource Estimate Completed for Alberta Asset (12/04/2019)

The report outlines a development plan for the project.

more>

Explorer to Sell Interest in Nevada Gold Project (12/04/2019)

In the arrangement, the company will garner a 1% net smelter return royalty.

more>

Company Vies for New Brunswick Cannabis Contract (12/04/2019)

The opportunity is one of the largest in retail cannabis in Canada.

more>

Royalty Company Closes Line of Credit Deal with Eric Sprott (12/04/2019)

The $6 million facility is available to the Vancouver-based firm until Nov. 29, 2021.

more>

Cannabis Producer Signs Supply Contract with Province of Alberta (12/04/2019)

To start, the company will introduce its premium brand of dried flower there.

more>

AR Tech Firm Reports Record November Revenue, Gross Profit (12/04/2019)

Increased sales spurred the growth during the month.

more>

Gold Company's Sale of Colombia Project Closes (12/04/2019)

The company will use the proceeds to explore its Nevada asset.

more>

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously (12/04/2019)

Daniel Carlson of Tailwinds Research initiates coverage on this clinical-stage biotech whose drug candidate works to strengthen the innate immune system.

more>

Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results (12/04/2019)

Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.

more>

Company Sells Nevada Asset to McEwen Mining, Retains Royalty (12/03/2019)

The transaction is in line with the Vancouver-based company's business model.

more>

AR Firm's Tech Now Integrates with Magento 2.0 E-Commerce Platform (12/03/2019)

The company believes the pairing should multiply the number of online sales that result from an augmented reality component.

more>

'Enormous Mineral Potential' Seen in Montana Mine Site (12/03/2019)

A site visit to this company's project generated optimism in James Kwantes of Resource Opportunities.

more>

Fund Manager's Top Performing Precious Metals Companies for 2019 (12/03/2019)

Ralph Aldis, portfolio manager at U.S. Global Investors, in this interview with Streetwise Reports, looks back at trends in 2019 and looks ahead to what we may expect in the precious metals in 2020; he also discusses the top performers in the precious metals fund that he manages.

more>

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial (12/03/2019)

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study.

more>

Vanadium Company Uncovers New Gold Target in Nevada Project (12/03/2019)

First Vanadium CEO Paul Cowley speaks with Peter Epstein of Epstein Research about the state of the vanadium market and his company's plans to explore the newly found gold target on the Carlin Trend in Nevada.

more>

Big Picture Outlook: Seat Belts Tightened (12/02/2019)

Sector expert Michael Ballanger offers his latest insights into the markets and his investment strategy as 2019 winds down.

more>

An Inside Look at Private Placements (12/02/2019)

Sector expert Maurice Jackson begins a four-part series on private placements with a conversation with Tekoa Da Silva of Sprott USA.

more>

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug (12/02/2019)

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic eye diseases.

more>

Riverside Resources Takes on New Project in Ontario (12/02/2019)

Freeman Smith, VP of exploration at Riverside Resources, speaks to Maurice Jackson of Proven and Probable about his company's exploration plans for its newest project in Ontario.

more>

Indonesia Rule on Nickel Helps Playfair Mining in Norway (12/01/2019)

Bob Moriarty of 321gold discusses the Indonesian government's actions in the nickel market and how they might affect a company with a project in Norway.

more>

More Archives

2019Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe